1. Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis 
Anne-Claire Toffart, MD, PhD, Michaël Duruisseaux, MD, PhD, Pierre-Yves Brichon, MD, PhD, Augustin Pirvu, MD, Julie Villa, MD, Laurent Selek, MD, PhD, Pascale Guillem, MD, Isabelle Dumas, MD, Léonie Ferrer, MD, Matteo Giaj Levra, MD, Denis Moro-Sibilot, MD 
The Annals of Thoracic Surgery 
Volume 105, Issue 3, Pages (March 2018)
DOI: /j.athoracsur
Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Flow chart of patients' treatments. (NSCLC = non-small cell lung cancer.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Characteristics of treatments for patients with synchronous solitary M1 (n = 109).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Survival of patients with synchronous solitary metastasis according to treatment (n = 109). (A) All the patients with or without chemotherapy (n = 109). (B) Operation at both sites with and without chemotherapy (n = 55). (C) Radiotherapy on both sites with and without chemotherapy (n = 31). (D) No curative treatment at either site, with and without chemotherapy (n = 19). (OS = overall survival.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

5. Supplemental Figure 1
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions